insights_auto
Why is TNDM up 3.93%?
Dive Deeperchevron_right
TNDM:NASDAQ
Tandem Diabetes Care Inc
$17.46
arrow_upward
+3.93%(+0.66) 1D
$17.48
arrow_upward
+0.11% (+0.020)bedtimeAfter hours
Closed: Nov 20, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNDM...
Open
$16.61
High
$17.86
Low
$16.51
Mkt. cap
1.22B
Avg. vol.
2.58M
Volume
2.67M
52-wk high
$29.65
52-wk low
$12.26
EPS
-$0.72
Beta
1.59
Shares outstanding
69.79M
No. of employees
2K
Open
$16.61
High
$17.86
Low
$16.51
Mkt. cap
1.22B
Avg. vol.
2.58M
Volume
2.67M
52-wk high
$29.65
52-wk low
$12.26
EPS
-$0.72
Beta
1.59
Shares outstanding
69.79M
No. of employees
2K
News stories
From web sources and news partners
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
About Tandem Diabetes Care Inc
CEOJohn Sheridan
Employees2.5K
FoundedJan 2006
Headquarters-
SectorHealth Care
IndustryMedical device
Websitetandemdiabetes.com